Anna Colomer

Institute Mutualiste Montsouris

Papers

4

Total Citations

22

H-Index

3

About

Anna Colomer is a leading urologic surgeon and researcher whose work focuses on advancing surgical techniques and outcomes for bladder cancer patients, particularly through robotic-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD). Her major contributions include pioneering the use of the Comprehensive Complication Index (CCI) to more accurately capture the true morbidity of RARC, moving beyond the limitations of the Clavien–Dindo Classification. She has also led multi-institutional studies examining the impact of perioperative blood transfusions on oncological outcomes, finding no adverse effects in the robotic setting, and demonstrating that continuing acetylsalicylic acid during surgery does not increase hemorrhagic complications. Her propensity-matched analyses show that RARC offers comparable or improved outcomes to open surgery for non-muscle-invasive bladder cancer. With over 20 citations across her most-cited works, Colomer’s research is shaping evidence-based guidelines for minimally invasive bladder cancer surgery, improving patient safety and recovery. Her work is essential reading for surgeons and researchers seeking to optimize perioperative care and long-term oncologic results in urologic oncology.

Research Focus

Key Achievements

3
H-Index
4
Papers
22
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Defining the Morbidity of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Adoption of the Comprehensive Complication Index
8 citations · 2022
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 46
🏛 Institutions: Institute Mutualiste Montsouris

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago